In patients with multiple sclerosis (MS), grey matter damage is widespread and might
underlie many of the clinical symptoms, especially cognitive impairment. This relation …

Cognitive impairment is a common and devastating manifestation of multiple sclerosis (MS).
Although disease-modifying therapies have been efficacious for reducing relapse rates in …

Classic cognitive theory conceptualizes executive functions as involving multiple specific
domains, including initiation, inhibition, working memory, flexibility, planning, and vigilance …

Multiple sclerosis (MS) is a progressive disease of the CNS that is characterised by
widespread lesions in the brain and spinal cord. MS results in motor, cognitive, and …

Cognitive impairment affects a large proportion of patients with multiple sclerosis (MS) and
has a profound impact on their daily-life activities. Improving the knowledge of the …

Multiple sclerosis (MS) is a neurological disorder affecting the central nervous system and
features extensive functional brain changes that are poorly understood but relate strongly to …

Background and Purpose—Determining cognitive dysfunctioning (CDF) after stroke is an
important issue because it influences choices for management in terms of return to previous …

Background: The default-mode network (DMN) has been increasingly recognized as
relevant to cognitive status. Objectives: To explore DMN changes in patients with relapsing …

The development of therapeutic strategies that promote functional recovery is a major goal
of multiple sclerosis (MS) research. Neuroscientific and methodological advances have …

Inflammatory demyelination and axon damage in the corpus callosum are prominent
features of multiple sclerosis (MS) and may partially account for impaired performance on …